National Academy of Clinical Biochemistry Laboratory Medicine Practice Guidelines: Follow-Up Testing for Metabolic Disease Identified by Expanded Newborn Screening Using Tandem Mass Spectrometry; Executive Summary
Dennis J. Dietzen(Washington University in St. Louis), Michael J. Bennett(Children's Hospital of Philadelphia), Ronald J. Whitley(University of Kentucky), W. Harry Hannon(Centers for Disease Control and Prevention), Stanley F. Lo(Children's Hospital of Wisconsin), William J. Rhead(Children's Hospital of Wisconsin), Uttam Garg(Children's Mercy Hospital), Piero Rinaldo(WinnMed)
Cited by 102
Related Papers
The cardiac phenotype induced by PPARα overexpression mimics that caused by diabetes mellitus
|Journal of Clinical Investigation|2002|879
Survival after Treatment with Phenylacetate and Benzoate for Urea-Cycle Disorders
|New England Journal of Medicine|2007|357
Targeted disruption of mouse long-chain acyl-CoA dehydrogenase gene reveals crucial roles for fatty acid oxidation
|Proceedings of the National Academy of Sciences|1998|254
‘Classical’ organic acidurias, propionic aciduria, methylmalonic aciduria and isovaleric aciduria: Long‐term outcome and effects of expanded newborn screening using tandem mass spectrometry
|Journal of Inherited Metabolic Disease|2006|247